The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1084/jem.20071501
The Journal of Experimental Medicine, Vol. 204, No. 8, 1731a-
The Rockefeller University Press, 0022-1007 $30.00
This Article
Right arrow Full Text (PDF, 599K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

COMMENTARY

Response to HHMI from Mike Rossner (Executive Director, The Rockefeller University Press) and Ira Mellman (Editor in Chief, the Journal of Cell Biology):


Figure 1
©cartoonbank.com. All Rights Reserved.

It seems clear from the HHMI response that they missed the point of our Editorial. They note that they are providing public access to HHMI-funded research with their outlay of cash to publishers (both commercial and non-commercial). This fact was not in dispute.

They do not, however, address the effect of their actions on the public access movement—that is, the effort to get publishers (especially commercial publishers, who have refused to release the bulk of their content to the public) to provide public access to their holdings after a short delay. If the Rockefeller University Press does not need reimbursement to provide free access after 6 months, neither should other publishers. Elsevier already makes vast sums of money publishing publicly funded research, and they should feel an obligation to give something back to the public. Paying publishers to provide spotty access to just a few of the papers they publish (e.g., those authored by HHMI investigators) does not address the issue of public access to all of the scientific literature. HHMI had an opportunity to exert some pressure on publishers to achieve that goal, and they chose not to do so. Although they claim they were trying to find a balance between public access and "scholarly freedom," they did not succeed. Instead, the public access movement has suffered because HHMI gave in to the selfish desire of some of their investigators to continue publishing in Cell. This serves neither the public, nor science.



Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?

Related Articles

A Reply from HHMI
Tom Cech, Jack Dixon, Avice Meehan, Josie Briggs, and Carl Rhodes
J. Exp. Med. 2007 204: 1731. [Full Text] [PDF]

How the rich get richer
Mike Rossner and Ira Mellman
J. Exp. Med. 2007 204: 1503. [Abstract] [Full Text] [PDF]




This Article
Right arrow Full Text (PDF, 599K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS